Figure 1.
Figure 1. DC maturation stages in tolerance induction. The bimodal concept of fully mature DCs as inducers of immunity as opposed to immature DCs as promoters of T-cell tolerance has been recently revisited. It is presently believed that DCs integrate a variety of incoming signals and decide whether protective immunity or Ag-specific unresponsiveness develops.7 Current experimental evidence supports the concept that cytokine-modulated semimature DCs promote the conversion of naive T cells into Tr1 cells and/or CD4+CD25+ Treg cells that inhibit effector T-cell responses via secreted or membrane-bound immunosuppressive cytokines. The inability to produce detectable amounts of bioactive IL-12p70 coupled with enhanced IL-10 release are unique functional features of cytokine-modulated, semimature TDCs.7,34,39,41 On the contrary, mature DCs might be crucially involved in the expansion of preformed Treg cells, as highlighted by in vitro studies performed with BM-derived, GM-CSF-modulated DCs and by in vivo treatment with complete Freund adjuvant (CFA) and GM-CSF-differentiated DCs.9 Illustration by Paulette Dennis.

DC maturation stages in tolerance induction. The bimodal concept of fully mature DCs as inducers of immunity as opposed to immature DCs as promoters of T-cell tolerance has been recently revisited. It is presently believed that DCs integrate a variety of incoming signals and decide whether protective immunity or Ag-specific unresponsiveness develops. Current experimental evidence supports the concept that cytokine-modulated semimature DCs promote the conversion of naive T cells into Tr1 cells and/or CD4+CD25+ Treg cells that inhibit effector T-cell responses via secreted or membrane-bound immunosuppressive cytokines. The inability to produce detectable amounts of bioactive IL-12p70 coupled with enhanced IL-10 release are unique functional features of cytokine-modulated, semimature TDCs.7,34,39,41  On the contrary, mature DCs might be crucially involved in the expansion of preformed Treg cells, as highlighted by in vitro studies performed with BM-derived, GM-CSF-modulated DCs and by in vivo treatment with complete Freund adjuvant (CFA) and GM-CSF-differentiated DCs. Illustration by Paulette Dennis.

Close Modal

or Create an Account

Close Modal
Close Modal